Scott Ellis Email and Phone Number
Scott Ellis work email
- Valid
- Valid
Scott Ellis personal email
A highly experienced leader with a strong background in human genetic disease, my time running critical teams in pioneering gene therapy companies has given me valuable experience in the successful development of therapeutic biologics, from concept through to clinical development. Extremely motivated, able to consistently achieve goals on time while motivating those around me into achieving theirs. Excellent management, organisation and communication skills, I can effectively and efficiently apply these skills to push forward existing programmes and identify and develop new programmes for novel disease targets.
-
Scientific Operating PartnerOxford Science Enterprises Jun 2024 - PresentOxford, England, GbA senior team member in a leading venture fund, work closely with the investment team, and providing leadership in the field working with Oxford University academic leaders in science. Working within the OSE Life Sciences Operating team supporting the growth and development of Life Science businesses, the identification of new opportunities, and formation of new spinouts from Oxford University.
-
Executive DirectorNovartis Feb 2022 - Apr 2024Basel, Baselstadt, ChFollowing the acquisition of Gyroscope by Novartis for $1.5B I was responsible for the management of the Gyroscope Research team and a member of the Ophthalmology Leadership team within the Novartis Institutes for Biomedical Research. -
Head Of Research And DevelopmentGyroscope Therapeutics Ltd Nov 2017 - Feb 2022I was responsible for Preclinical Development of pipeline and platform at Gyroscope, an innovative AAV gene therapy company in the UK targeting chronic ocular diseases. I was ultimately responsible for completion of preclinical data packages for our lead asset (GT005, currently in 2 parallel Phase II clinical trials) and follow-up asset (IND-ready), and have initiated several programmes for completely new indications. Recognising the future need to expand patient access to gene therapies, I have also driven the development of our AAV gene therapy platform to ensure we remain competitive into the future. I have represented the Research function at several Regulatory meetings, have organised Scientific Ad Boards and have identified key strategic research areas to expand into that will be important for the future sustainability of the pipeline.
-
Head Of Early DevelopmentOxford Biomedica Nov 2006 - Nov 2017Oxford, Oxfordshire, GbI was responsible for the research and development of gene and cell therapies at Oxford BioMedica. My departments main focus was the development of innovative therapies for the treatment of chronic conditions based on our proprietary LentiVector® platformMy role at Oxford BioMedica was wide-ranging and included managing basic research, therapeutic vector design and optimisation, generation of preclinical/nonclinical data, through to preparation of Regulatory submissions, Clinical trial design and data analysis/interpretation, and Business Development activities. I have presented at many international scientific conferences and have published in the gene therapy field in leading peer-reviewed journals. -
Senior Postdoctoral Research ScientistWellcome Trust Centre For Human Genetics, University Of Oxford 2002 - Nov 2006Oxford, GbInvestigating why fibrinogen, a well-known risk factor for cardiovascular disease, is found at elevated plasma levels in a proportion of the population. I was also brought into the PROCARDIS project, a joint collaborative study co-ordinated at Oxford, involving academic groups from the UK, Sweden, Italy and Germany, as well as industry partners AstraZeneca and Oxagen. The project involved a genome-wide scan to identify susceptibility loci in precocious coronary artery disease. -
Postdoctoral Research FellowBrunel University London 1998 - 2002Uxbridge, Middlesex, GbIdentifying tumour suppressor genes (especially telomerase repressor genes) by microcell-mediated chromosome transfer, an extremely powerful, cell-based technique based on genomic complementation.
Scott Ellis Skills
Scott Ellis Education Details
-
National Institute For Medical ResearchRetrovirology And Mouse Genetics -
University Of BathApplied Biology
Frequently Asked Questions about Scott Ellis
What company does Scott Ellis work for?
Scott Ellis works for Oxford Science Enterprises
What is Scott Ellis's role at the current company?
Scott Ellis's current role is Scientific Operating Partner at Oxford Science Enterprises.
What is Scott Ellis's email address?
Scott Ellis's email address is s.****@****a.co.uk
What schools did Scott Ellis attend?
Scott Ellis attended National Institute For Medical Research, University Of Bath.
What skills is Scott Ellis known for?
Scott Ellis has skills like Molecular Biology, Cell Culture, Cell Biology, Biochemistry, Qpcr, Elisa, Pcr, Cell, Clinical Development, Assay Development, Immunology, Protein Purification.
Free Chrome Extension
Find emails, phones & company data instantly
Aero Online
Your AI prospecting assistant
Select data to include:
0 records × $0.02 per record
Download 750 million emails and 100 million phone numbers
Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.
Start your free trial